News & Updates

Treatment with rosuvastatin, given at moderate and high intensity doses, as well as simvastatin and atorvastatin, given at high intensity doses, modestly reduce levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) in diabetic patients over 12 weeks compared with placebo, a study has shown.

In children with type 1 diabetes (T1D), glycated haemoglobin A1c (HbA1c) significantly decreases at 12 months after diagnosis with the help of a technology-enabled, team-based approach to intensified new-onset education involving target setting, continuous glucose monitoring (CGM), and remote data review, results of a study have shown.

Glaucoma appears to be associated with high total cholesterol and low high-density lipoprotein (HDL) levels, according to a systematic review and meta-analysis of observational studies.